Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Journal of Southern Medical University ; (12): 1262-1263, 2007.
Artículo en Chino | WPRIM | ID: wpr-283155

RESUMEN

<p><b>OBJECTIVE</b>To investigate the relationship between lamivudine-resistant mutants of hepatitis B virus (HBV) and serum HBV DNA loading before antiviral therapy.</p><p><b>METHODS</b>This study involved 106 patients with hepatitis B receiving lamivudine treatment for an average of 32 months (rang 12-48 months). Serum HBV DNA loadings were measured with PCR before and every 4 to 6 months during lamivudine therapy. HBV YMDD mutants were detected using mismatched PCR-restriction fragment length polymorphism (PCR-RFLP) during lamivudine treatment.</p><p><b>RESULTS</b>HBV DNA loading was significantly higher in patients infected with HBV YMDD mutants during lamivudine therapy than those infected with HBV without YMDD mutation.</p><p><b>CONCLUSION</b>High viral loading in hepatitis B patients before treatment is associated with high likeliness of HBV YMDD mutation during lamivudine treatment. HBV DNA loading may be indicative for the occurrence of YMDD mutation during lamivudine therapy.</p>


Asunto(s)
Femenino , Humanos , Masculino , Persona de Mediana Edad , Antivirales , Farmacología , ADN Viral , Sangre , Farmacorresistencia Viral , Genética , Hepatitis B , Sangre , Virus de la Hepatitis B , Genética , Fisiología , Lamivudine , Farmacología , Mutación , Carga Viral , Genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA